ASMR

• N=25 • Period: 2004-2006 • Median age: 26 months (range, 2,4 months-19,5 years) • Multimodality treatment: (surgery+/-radiation therapy [54 Gy at 2 Gy/fraction, N=15]+/-chemo)

The objective response rate observed after RT was 38%.

The 2-year progression-free and overall survival rates are 53% ± 13% and 70% ± 10%,

J Clin Oncol. 2009 January 20; 27(3): 385–389.